Among elderly people on ACE inhibitors therapy, the eGFR in non-AKI group was 78.15±25.7 ml/min/1.73 m2versus 64.16±22.97 ml/min/1.73 m2 in AKI group (P<0.0001). The gene discussed is ACE; the disease is acute kidney injury.